Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

The impact of migration on tuberculosis epidemiology and control in high-income countries: a review.

Pareek M, Greenaway C, Noori T, Munoz J, Zenner D.

BMC Med. 2016 Mar 23;14:48. doi: 10.1186/s12916-016-0595-5. Review.

2.

Mind the gap: TB trends in the USA and the UK, 2000-2011.

Nnadi CD, Anderson LF, Armstrong LR, Stagg HR, Pedrazzoli D, Pratt R, Heilig CM, Abubakar I, Moonan PK.

Thorax. 2016 Apr;71(4):356-63. doi: 10.1136/thoraxjnl-2015-207915. Epub 2016 Feb 23.

3.

Extensively drug-resistant tuberculosis in a young child after travel to India.

Salazar-Austin N, Ordonez AA, Hsu AJ, Benson JE, Mahesh M, Menachery E, Razeq JH, Salfinger M, Starke JR, Milstone AM, Parrish N, Nuermberger EL, Jain SK.

Lancet Infect Dis. 2015 Dec;15(12):1485-91. doi: 10.1016/S1473-3099(15)00356-4. Epub 2015 Nov 16. Review.

4.

Challenges in Obtaining Estimates of the Risk of Tuberculosis Infection During Overseas Deployment.

Mancuso JD, Geurts M.

Am J Trop Med Hyg. 2015 Dec;93(6):1172-8. doi: 10.4269/ajtmh.15-0539. Epub 2015 Sep 28.

5.

Screening travellers to high-endemic countries for infection with Mycobacterium tuberculosis using interferon gamma release assay; a prospective study.

Elfrink F, van den Hoek A, Mensen ME, Sonder GJ.

BMC Infect Dis. 2014 Sep 23;14:515. doi: 10.1186/1471-2334-14-515.

6.

Tuberculosis in tropical areas and immigrants.

Zammarchi L, Bartalesi F, Bartoloni A.

Mediterr J Hematol Infect Dis. 2014 Jun 1;6(1):e2014043. doi: 10.4084/MJHID.2014.043. eCollection 2014. Review.

7.

Impact of targeted testing for latent tuberculosis infection using commercially available diagnostics.

Mancuso JD, Tribble D, Mazurek GH, Li Y, Olsen C, Aronson NE, Geiter L, Goodwin D, Keep LW.

Clin Infect Dis. 2011 Aug 1;53(3):234-44. doi: 10.1093/cid/cir321.

8.

Tuberculosis among participants in an academic global health medical exchange program.

Gardner A, Cohen T, Carter EJ.

J Gen Intern Med. 2011 Aug;26(8):841-5. doi: 10.1007/s11606-011-1669-x. Epub 2011 Feb 26.

9.

Tuberculosis: evidence review for newly arriving immigrants and refugees.

Greenaway C, Sandoe A, Vissandjee B, Kitai I, Gruner D, Wobeser W, Pottie K, Ueffing E, Menzies D, Schwartzman K; Canadian Collaboration for Immigrant and Refugee Health..

CMAJ. 2011 Sep 6;183(12):E939-51. doi: 10.1503/cmaj.090302. Epub 2010 Jul 15. Review.

10.

Illness in long-term travelers visiting GeoSentinel clinics.

Chen LH, Wilson ME, Davis X, Loutan L, Schwartz E, Keystone J, Hale D, Lim PL, McCarthy A, Gkrania-Klotsas E, Schlagenhauf P; GeoSentinel Surveillance Network..

Emerg Infect Dis. 2009 Nov;15(11):1773-82. doi: 10.3201/eid1511.090945.

11.

Tuberculosis screening of travelers to higher-incidence countries: a cost-effectiveness analysis.

Tan M, Menzies D, Schwartzman K.

BMC Public Health. 2008 Jun 5;8:201. doi: 10.1186/1471-2458-8-201.

12.

Interferon-gamma and skin test responses of schoolchildren in southeast England to purified protein derivatives from Mycobacterium tuberculosis and other species of mycobacteria.

Weir RE, Fine PE, Nazareth B, Floyd S, Black GF, King E, Stanley C, Bliss L, Branson K, Dockrell HM.

Clin Exp Immunol. 2003 Nov;134(2):285-94.

Supplemental Content

Support Center